SOPHARMA AD - Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_capital_increase_price_correction_10072025_EN_espi.pdfAdjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 81 / 2025

Date of issue: 2025-07-10

Short name of the issuer

SOPHARMA AD

Subject

Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

Annexes

File Description

SFA_capital_increase_price_correction_10072025_EN_espi.pdfSFA_capital_increase_price_correction_10072025_EN_espi.pdf Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2025-07-10 Ognian Donev Executive Director